Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	622.35B +19.8%
Revenue (ttm)	825.44B +1.8%
Net Income	24.39B -33.2%
EPS	1,999.54 -33.0%
Shares Out	12.20M
PE Ratio	25.51
Forward PE	n/a
Dividend	680.00 (1.33%)
Ex-Dividend Date	Nov 24, 2025

Volume	45,904
Average Volume	49,057
Open	49,150
Previous Close	50,200
Day's Range	47,500 - 51,000
52-Week Range	31,500 - 65,900
Beta	1.04
RSI	52.10
Earnings Date	Feb 13, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.